Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 457.0
(-2.35%)
JPY 457.0
(-2.35%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 228.56 Million JPY | -3.81% |
| 2022 | 237.62 Million JPY | 26.88% |
| 2021 | 187.28 Million JPY | -8.23% |
| 2020 | 204.07 Million JPY | 22.9% |
| 2019 | 166.04 Million JPY | 13.52% |
| 2018 | 146.27 Million JPY | 8.2% |
| 2017 | 135.18 Million JPY | 28.57% |
| 2016 | 105.14 Million JPY | -14.67% |
| 2015 | 123.22 Million JPY | -10.72% |
| 2014 | 138.01 Million JPY | 28.95% |
| 2013 | 107.03 Million JPY | 50.05% |
| 2012 | 71.32 Million JPY | 11.99% |
| 2011 | 63.69 Million JPY | 9.37% |
| 2010 | 58.23 Million JPY | -33.64% |
| 2009 | 87.75 Million JPY | 119.8% |
| 2008 | 39.92 Million JPY | 8.82% |
| 2007 | 36.68 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 240.47 Million JPY | 5.21% |
| 2024 Q2 | 188.28 Million JPY | -21.7% |
| 2023 Q1 | 227.72 Million JPY | -4.17% |
| 2023 Q3 | 216.32 Million JPY | 9.75% |
| 2023 FY | 228.56 Million JPY | -3.81% |
| 2023 Q2 | 197.09 Million JPY | -13.45% |
| 2023 Q4 | 228.56 Million JPY | 5.66% |
| 2022 Q4 | 237.62 Million JPY | -11.77% |
| 2022 Q3 | 269.31 Million JPY | 36.67% |
| 2022 Q2 | 197.05 Million JPY | -11.46% |
| 2022 Q1 | 222.56 Million JPY | 18.84% |
| 2022 FY | 237.62 Million JPY | 26.88% |
| 2021 Q4 | 187.28 Million JPY | -15.45% |
| 2021 Q3 | 221.5 Million JPY | -8.19% |
| 2021 Q2 | 241.27 Million JPY | 0.74% |
| 2021 Q1 | 239.5 Million JPY | 17.36% |
| 2021 FY | 187.28 Million JPY | -8.23% |
| 2020 FY | 204.07 Million JPY | 22.9% |
| 2020 Q2 | 263.38 Million JPY | 13.17% |
| 2020 Q3 | 315.4 Million JPY | 19.75% |
| 2020 Q4 | 204.07 Million JPY | -35.3% |
| 2020 Q1 | 232.73 Million JPY | 40.17% |
| 2019 Q1 | 184.56 Million JPY | 26.18% |
| 2019 Q2 | 171.85 Million JPY | -6.88% |
| 2019 Q3 | 207.86 Million JPY | 20.95% |
| 2019 FY | 166.04 Million JPY | 13.52% |
| 2019 Q4 | 166.04 Million JPY | -20.12% |
| 2018 FY | 146.27 Million JPY | 8.2% |
| 2018 Q2 | 170.15 Million JPY | 21.25% |
| 2018 Q1 | 140.33 Million JPY | 3.81% |
| 2018 Q3 | 176.04 Million JPY | 3.46% |
| 2018 Q4 | 146.27 Million JPY | -16.91% |
| 2017 Q4 | 135.18 Million JPY | -9.82% |
| 2017 FY | 135.18 Million JPY | 28.57% |
| 2017 Q3 | 149.91 Million JPY | 54.37% |
| 2017 Q2 | 97.11 Million JPY | -10.21% |
| 2017 Q1 | 108.16 Million JPY | 2.87% |
| 2016 FY | 105.14 Million JPY | -14.67% |
| 2016 Q2 | 98.69 Million JPY | -12.36% |
| 2016 Q3 | 123.79 Million JPY | 25.44% |
| 2016 Q4 | 105.14 Million JPY | -15.07% |
| 2016 Q1 | 112.61 Million JPY | -8.61% |
| 2015 Q1 | 153.15 Million JPY | 10.97% |
| 2015 FY | 123.22 Million JPY | -10.72% |
| 2015 Q4 | 123.22 Million JPY | -19.18% |
| 2015 Q3 | 152.45 Million JPY | 14.69% |
| 2015 Q2 | 132.92 Million JPY | -13.21% |
| 2014 Q3 | 139.13 Million JPY | 9.45% |
| 2014 Q2 | 127.12 Million JPY | -3.79% |
| 2014 FY | 138.01 Million JPY | 28.95% |
| 2014 Q1 | 132.13 Million JPY | 23.45% |
| 2014 Q4 | 138.01 Million JPY | -0.8% |
| 2013 Q3 | 90.65 Million JPY | 4.45% |
| 2013 FY | 107.03 Million JPY | 50.05% |
| 2013 Q2 | 86.79 Million JPY | 9.33% |
| 2013 Q4 | 107.03 Million JPY | 18.07% |
| 2013 Q1 | 79.38 Million JPY | 11.29% |
| 2012 Q2 | 74.12 Million JPY | 8.86% |
| 2012 Q1 | 68.09 Million JPY | 6.92% |
| 2012 Q3 | 65.53 Million JPY | -11.6% |
| 2012 Q4 | 71.32 Million JPY | 8.85% |
| 2012 FY | 71.32 Million JPY | 11.99% |
| 2011 Q2 | 68.88 Million JPY | 8.6% |
| 2011 Q3 | 61.1 Million JPY | -11.29% |
| 2011 Q4 | 63.69 Million JPY | 4.23% |
| 2011 FY | 63.69 Million JPY | 9.37% |
| 2011 Q1 | 63.42 Million JPY | 8.92% |
| 2010 Q2 | 88.98 Million JPY | 32.22% |
| 2010 FY | 58.23 Million JPY | -33.64% |
| 2010 Q3 | 72.19 Million JPY | -18.87% |
| 2010 Q4 | 58.23 Million JPY | -19.34% |
| 2010 Q1 | 67.3 Million JPY | -23.31% |
| 2009 Q4 | 87.75 Million JPY | 5.54% |
| 2009 Q2 | 58.57 Million JPY | 37.13% |
| 2009 Q1 | 42.71 Million JPY | 6.99% |
| 2009 Q3 | 83.15 Million JPY | 41.96% |
| 2009 FY | 87.75 Million JPY | 119.8% |
| 2008 Q4 | 39.92 Million JPY | -4.61% |
| 2008 FY | 39.92 Million JPY | 8.82% |
| 2008 Q3 | 41.85 Million JPY | 0.0% |
| 2007 FY | 36.68 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 66.536% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -1174.834% |
| GNI Group Ltd. | 2.33 Billion JPY | 90.193% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 89.74% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -238.71% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 79.608% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -120.763% |
| AnGes, Inc. | 1.61 Billion JPY | 85.854% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -208.876% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 92.127% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 28.998% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -124120.109% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -63.098% |
| CanBas Co., Ltd. | 728 Thousand JPY | -31296.291% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -160.138% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -54.499% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -256.537% |
| Kidswell Bio Corporation | 875.65 Million JPY | 73.898% |
| PeptiDream Inc. | 2.4 Billion JPY | 90.493% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -4178.641% |
| Ribomic Inc. | 2.27 Million JPY | -9951.231% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -22856499900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -534.903% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -688.155% |
| CellSource Co., Ltd. | 305.92 Million JPY | 25.287% |
| FunPep Company Limited | 25.54 Million JPY | -794.894% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 37.217% |
| Stella Pharma Corporation | 1.11 Billion JPY | 79.524% |
| TMS Co., Ltd. | 50.02 Million JPY | -356.902% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -993.56% |
| Cuorips Inc. | 1.04 Million JPY | -21814.19% |
| K Pharma,Inc. | 10.79 Million JPY | -2017.519% |
| Takara Bio Inc. | 11.85 Billion JPY | 98.071% |
| ReproCELL Incorporated | 248.14 Million JPY | 7.889% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 49.274% |
| StemCell Institute Inc. | 42.26 Million JPY | -440.829% |
| CellSeed Inc. | 46.19 Million JPY | -394.826% |